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The rapid reaction of a-clostripain with tosyl-L-lysine chloromethyl ketone results in a complete loss of 
activity and in the disappearance of one titratable SH group whereas the number of histidine residues is 
not affected. Tosyl-L-phenylalanine chloromethyl ketone and phenylmethylsulfonyl fluoride have no 
effect on the catalytic activity. From the molar ratio and under the assumption of 1: 1 molar interaction, 
the fully active enzyme has a specific activity of 650-700 units/mg [twice the value proposed by Porter 
et al. (J. Biol. Chem. 246 (1971) 76757682)]. Partial oxidation makes it experimentally impossible to 
attain this maximal value. 
ff-Clostripain Cysteine proteinase Active site 
1. INTRODUCTION 
Clostripain (EC 3.4.4.20) is a sulfhydryl protein- 
ase isolated from the culture filtrate of Clostridium 
histolyticum with a highly limited specificity 
directed at the carboxyl bond of arginyl residues in 
proteins and in synthetic substrates [l-4]. Accord- 
ing to the specificity, clostripain is close to trypsin- 
like enzymes; on the other hand, its catalytic site is 
that of a SH-proteinase. 
In [4], we isolated a highly active form of clostri- 
pain: cY-clostripain of spec. act. 550-600 units/mg. 
Our preliminary study on the reaction of this pro- 
teinase with TLCK supported the hypothesis in [5] 
suggesting that the inhibition of activity by TLCK 
Abbreviations: TLCK, N-a-p-tosyl-L-lysine chloro- 
methyl ketone; TPCK, N-cY-p-tosyl-L-phenylalanine 
chloromethyl ketone; PMSF, phenylmethylsulfonyl 
fluoride; BAEE, ru-N-benzyl-L-arginine ethyl ester; 
DTT, dithiothreitol; DTNB, 5,5’-dithiobis(2_nitroben- 
zoic acid); p-NOz-ZACK, N-cu-p-nitrobenzyloxycar- 
bonyl-L-arginine chloromethyl ketone 
was due to the modification of a thiol group in an 
analogous way with other cysteine proteinases uch 
as papain [6] and ficin [7]. Recently [8], we eluci- 
dated the amino acid sequence around this acces- 
sible thiol group after labelling with radioactive 
iodoacetic acid. 
We investigate here the chemistry of the active 
site of u-clostripain by a detailed study of the reac- 
tion of cu-clostripain with TLCK. It is shown that 
TLCK reacts with the sulfhydryl group of (Y-clos- 
tripain and that there is no reaction with histidine 
residues. 
2. MATERIALS AND METHODS 
Culture filtrates of C. histolyticum were obtained 
from Institute Pasteur Production. BAEE was ob- 
tained from Fluka. DTT (Cleland’s reagent) and 
PMSF were from Sigma and TPCK from Merck. 
DTNB was purchased from Pierce. Ultrogel AcA 
202 was obtained from IBF. All other chemicals 
used were of analytical grade of the highest quality 
available. 
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2.1. Enzyme purification 
cu-Clostripain was isolated from the culture fil- 
trate of C. histolyticum as described in [4]. Instead 
of lyophilisation, the final solution of the pure 
enzyme was distributed into tubes, flushed with 
nitrogen, then frozen. 
2.2. TLCK inhibition studies 
Titrations of free thiol groups in the native or 
modified enzyme were carried out at pH 7.0 as fol- 
lows: to one cuvette, 0.2ml enzyme solution and 
0.8 ml of 0.1 M buffer (pH 7.0) (Tris/HCl or phos- 
phate) were added. The control cuvette contained 
1 ml of the same buffer. 0.020 ml of 10 mM DTNB 
was added to both cuvettes and the increase in A412 
was recorded. 
Reactions were carried out at room temperature 
or 4°C. In a typical experiment, cu-clostripain was 
activated in 50mM Tris-HCI buffer containing 
10mM DTT for 1 h at 4°C. Exogenous reducing 
agent was then eliminated by passage over an 
AcA 202 (0.9 x 20 cm) column equilibrated and 
eluted with 0.1 M Tris-HCI buffer (pH 7.0). Im- 
mediately after the removal of DTT, an appropriate 
concentration of TLCK in Hz0 was added to the 
aliquots of this activated enzyme solution. At 
various times during the course of the reaction, ali- 
quots were assayed for residual activity with BAEE 
and sulfhydryl content by spectrophotometric titra- 
tion. 
2.5. Amino acid analyses 
Amino acid analyses were performed on a 
Beckman Multichrom B apparatus equipped with 
an Icap 10 Integrator using a single column pro- 
cedure [lo]. Samples were hydrolyzed in 6 N HCl 
for 20 h at 110°C under vacuum. Half-cystine was 
estimated as cysteic acid after performic acid oxi- 
dation [l I]. 
3. RESULTS 
3.1. Inhibition of a-clostripain by alkylating re- 
agents 
For the study of the effect of pH on inhibition 
by TLCK, the buffers used were acetate (pH 3% 
5.8), phosphate (pH 5.8-7.8) and borate (7.5-9.6). 
The total ionic strength was maintained at 0.3 by 
addition of KCl. 
2.3. Enzyme assay 
The standard assay of a-clostripain was based 
on the spectrophotometric determination of the 
initial rate of hydrolysis of BAEE using 2-ml ali- 
quots of 50 mM Tris-HCl, 50mM CaClz buffer 
(pH 7.4) containing 0.75 mM BAEE without DTT. 
Initial rates were determined with a Zeiss PMQ-11 
recording spectrophotometer at 25°C. A molar ab- 
sorption difference of 1150 M-l. cm-’ was used in 
all calculations. 
At 4”C, pH 7.0 and a TLCK:enzyme molar 
ratio of 1: 1, TLCK rapidly and irreversibly in- 
hibits the esterase activity of a-clostripain, since 
within 60 s of the reaction, the residual activity was 
less than 0.5% (fig.1). The extent of inhibition 
reaches the maximum value between pH4-5; 
above this value it remains stable (fig.2). As the 
reaction is fast, it is not influenced by the known 
instability of TLCK under alkaline conditions [ 121. 
In contrast to TLCK, even a lOOO-fold molar ex- 
cess of TPCK of PMSF over an extended period of 
time failed to inhibit the enzyme. 
HgClz-treated clostripain did not react with even 
a IO-fold molar excess of TLCK and the subse- 
quent removal of the mercury by dithiothreitol re- 
stored completely the original activity. 
2.4. Tritration of the thiol groups in the enzyme 
with DTNB 
3.2. Stoichiometry of inhibition of a-clostripain 
by TLCK 
Thiol estimations were calculated on the basis of Although the preparation of a-clostripain used 
a molar absorbance of 13 600 for 5-carboxy-4-nitro- for the inhibition experiments was homogeneous 
thiophenol at 412 nm 191. The ,441~ was read against and the conditions for its maximum reductive acti- 
the blank treated in parallel but with no protein. vation were maintained, the inhibition was com- 
The production of 5-carboxy-4-nitrothiophenol plete by less than a molar equivalent of TLCK 
was measured and recorded with a Perkin-Elmer calculated from the Mr of the proteinase (fig.1). 
model 550 S recording spectrophotometer (sen- The apparent molar concentrations of solutions of 
sitivity of the recorder permitted us to record an a-clostripain as determined by titration with 
absorbance of 0.050 or 0.100 as full scale). TLCK were typically 70-80%. The corollary of 
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Fig.1. Effect of TLCK on the enzymatic activity of 
a-clostripain. cY-Clostripain (spec. act. 440 units/mg) 
concentration: 3.6 x 10e6M. Reactions were carried in 
0.1 M phosphate buffer (pH 7.0) at 0°C without DTT. 
Curve 1, 4 x 10e6M TLCK; curve 2, 2.8 x 10d6M 
TLCK; curve 3, 2.0 x 10e6M TLCK. 
this is that the true specific activity of the fpction 
corresponding to the fully active enzyme in the rate 
assays is approx. 1.3-times the values we usually 
obtain with our preparations. For example, with 
our procedure of purification [4], we generally ob- 
PH 
Fig.2. Effect of pH on the reactivity of TLCK with 
cY-clostripain. Incubation was at 0°C. Concentration: 
0.82 x 10e6M, cY-clostripain; 0.25 x 10m6M, TLCK. 
Buffers: sodium acetate (pH 3.75, 4.10, 4.50 and 5.0); 
sodium phosphate (pH 5.80, 6.00, 6.25, 6.93 and 7.26); 
sodium borate (pH 7.77, 8.15,8.90 and 9.35). The graph 
Fig.3. Typical recording at 412nm (A) of titration of 
accessible SH group of cr-clostripain by DTNB after 
reaction with TLCK. a-Clostripain was at 1.8 x 10e6 M 
and was 60% catalytically active. Curve 1 without TLCK; 
curve 2, 0.2 x 10m6M TLCK; curve 3, 0.42 x 10m6M 
TLCK; curve 4, 0.62 x 10e6M TLCK; curve 5, 
0.85 x 10m6 M TLCK; curve 6, 1.1 x low6 M TLCK and 
4.0 x 10e6 M TLCK. The percentage of residual activity 
is the result of two experiments (v, A). is reported. 
tained an enzyme of apparent homogeneity and of 
spec. act. about 550-600 units/mg (on a-N- 
benzoyl-L-arginine ethyl ester) whereas the titra- 
tion with TLCK gives a value of about 650-700 
units/mg of completely active clostripain. The 
major reason why a preparation of fully activated 
a-clostripain cannot be obtained is its sensitivity to 
oxidation. Even after repeated removal of inactive 
clostripain by an w-aminoalkylagarose column, 
partial oxidation always takes place. Consequently, 
apparent inhibition of a-clostripain by a less than 
equimolar quantity of TLCK is the result of the 
presence of catalytically inactive clostripain. 
3.3. Sulfhydryl group as the site of alkylation of 
mu-clostripain by TLCK 
Simultaneously with the measurement of resi- 
dual activity during TLCK treatment, the sulf- 
hydryl content of the inactivated enzyme was 
determined by spectrophotometric titration with 
DTNB. A typical example is reported in fig.3 and 
illustrates the loss of titratable sulfhydryl goups 
concomitant with the loss in activity. In this experi- 
ment, a solution of 60% catalytically active cu-clos- 
tripain had 0.8 titratable SH group. To this solu- 
tion, TLCK at different molar ratios of inhibitor 
to enzyme was added and the residual titratable 
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No. of modified SH groups 
Fig.4. Relationship between the residual esterase activity 
of cY-clostripain and the degree of substitution of the 
sulfhydryl group by TLCK at pH 7.0 and 0°C in the case 
of fully active enzyme (spec. act. 650-700 units/mg). 
The graph is the result of 3 experiments. 
sulfhydryl groups were recorded. It was observed 
that even after complete loss of activity resulting 
from extended incubation with TLCK, about 20% 
of the sulfhydryl groups remained (fig.3, curve 6). 
The reaction of the sulfhydryl groups of a-clostri- 
pain with TLCK is dependent upon the active en- 
zyme; the number of moles of sulfhydryl groups 
blocked per mole of enzyme by TLCK corres- 
ponded exactly to the fraction of active enzyme 
(normality) as determined by the assay with BAEE. 
Fig.4 illustrates the relation between the loss in 
activity and the number of labelled sulfhydryl 
groups in the case of fully active a-clostripain. A 
comparison of the amino acid analyses of the in- 
hibited enzyme with the uninhibited control reveals 
that the only amino acid to have undergone a sig- 
nificant change was cysteine (8.2 residues found 
instead of 8.9) and that no decrease of histidine 
residues was observed (9.1 residues in both cases). 
4. DISCUSSION 
According to this study, TLCK inactivates CZ- 
clostripain by reacting with a sulfhydryl group. 
The results in support of this include: (i) loss of 
one titratable free sulfhydryl group simultaneous 
with loss of activity; (ii) loss of a cysteine residue 
as determined by amino acid analysis where there 
is no significant change in any of the other amino 
acids; (iii) HgClz-treated clostripain is not inacti- 
vated by TLCK; (iv) the stoichiometry of the reac- 
tion indicates that one TLCK reacts with one sulf- 
hydryl group of cu-clostripain which results in com- 
plete loss of activity. The conclusion that TLCK 
reacts with the sulfhydryl group of a-clostripain is 
in agreement with our preliminary study on the 
reaction of TLCK with clostripain [4] and with the 
hypothesis of authors in [5] on the mechanism of 
the reaction of TLCK with two other SH-protein- 
ases, namely, papain [6] and ficin [7]. 
The reaction of a-clostripain with TLCK differs, 
however, in some aspects from that of trypsin or 
papain. 
First, as in the case of papain [6], the rate of 
reaction of TLCK with clostripain is much faster 
than with trypsin. Under similar reaction condi- 
tions, 99% of the activity of a-clostripain is lost 
after 1 min incubation compared to 80% for tryp- 
sin after 1 h reaction. Second, TLCK reacts with 
the sulfhydryl group rather than with the imidazole 
group of a specific histidine as it does in the case 
of trypsin. On the basis of nucleophilicity alone, 
one can expect the attack of this chloromethyl 
ketone on a sulfhydryl group to be favored over 
that on an imidazole group. This was clearly illus- 
trated by authors in [ 131 who succeeded in conver- 
ting the hydroxyl group of the active-serine of tryp- 
sin into a thiol group without a drastic change in 
the activity. In this thiol trypsin, TLCK reacted 
with the new thiol group with subsequent loss of 
activity without modification of histidine residues. 
A third way in which the reactions differ is in the 
nature of the pH-profile of the reaction. For tryp- 
sin, the reaction with TLCK indicated dependence 
on a group with pK, = 6.25 assignable to a histi- 
dine residue [12]. In the case of papain, the reac- 
tion with TPCK is dependent on a single prototro- 
pit group of pK8.9 indicating the involvement of 
a sulfhydryl group [6]. For a-clostripain, taking in 
account the interactive active-center system charac- 
terized by two p& values of approx. 4 and 9 [14], 
the high reactivity with TLCK at a pH value around 
4.5 may be attributed to the formation of the inter- 
active system from a thiol, rendered nucleophilic, 
with the imidazole group of one histidine and which 
produces the nucleophilic ion pair ImH+/S-. 
Another difference between papain and ~clos- 
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tripain is in the specificity of the reaction. Both 
TPCK and TLCK inhibit papain with the latter 
reacting at a faster rate. Papain is also rapidly in- 
hibited by reaction with PMSF. In the case of CX- 
clostripain only TLCK reacts. The rapid attack by 
TLCK on the active site would appear to contra- 
dict the restricted arginine specificity. In a previous 
study in our laboratory, an arginine cloromethyl 
ketone (p-N02-ZACK) was prepared in pure form 
and assayed with cy-clostripain; it was evident that 
this reagent is extremely effective in the inactiva- 
tion of both clostripain and trypsin [ 151. During 
this study, however, this highly unstable reagent 
[ 16-181 was not available. 
The present work gives direct evidence that 
TLCK inactivates Lu-clostripain stoichiometrically 
and that the reaction of the sulfhydryl group of 
clostripain with TLCK is dependent upon an active 
enzyme. After complete loss of activity on incuba- 
tion with TLCK, some sulfhydryl groups remained. 
Furthermore, the number of moles of sulfhydryl 
groups reacted per mole of enzyme corresponds 
exactly to the fraction of active enzyme (normality) 
as determined by reaction with BAEE. Thus, one 
can determine the operational normality of a clos- 
tripain solution by use of TLCK and DTNB to 
titrate the sulfhydryl groups. In the absence of a 
‘burst assay’ such as that with p-nitrophenyl-p’- 
guanidinobenzoate for trypsin [ 191, TLCK can be 
used as active-site directed inhibitor for cu-clostri- 
pain. 
Several other reagents have been proposed for 
the active-site cysteine residue in other proteinases: 
these include 2,2’-dipyridyl disulfide [20] and more 
recently the peptidyldiazomethanes [21]. The latter 
are unreactive with free cysteine but react irre- 
versibly and rapidly in high dilution exclusively with 
thiol proteinases; they can be synthesized to satisfy 
the specificity of individual members of the thiol 
proteinase family. E64 [L-truns-epoxysuccinyl- 
L-leucylamido(4-guanidino)butane], proposed as 
specific inhibitor for the cysteine proteinases, has 
no effect on cr-clostripain [22]. 
In [8], we have isolated a tryptic peptide con- 
taining the sulfhydryl group of a cysteine residue 
labelled with iodo[ 1 -14C]acetic acid. This cysteine 
residue is located in position 41 of the heavy chain. 
The sequence of this peptide shows no homology 
with other cysteine proteinases such as papain, 
ficin, cathepsin B or streptococcal proteinase. 
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